Avita Medical
RCEL
76 hedge funds and large institutions have $26.3M invested in Avita Medical in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 35 reducing their positions, and 20 closing their positions.
182% more call options, than puts
Call options by funds: $1.13M | Put options by funds: $400K
5% less funds holding
Funds holding: 80 → 76 (-4)
10.05% less ownership
Funds ownership: 29.07% → 19.02% (-10%)
20% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 20
35% less capital invested
Capital invested by funds: $40.7M → $26.3M (-$14.4M)
63% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$522K |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$508K |
| 3 |
HF
HRT Financial
New York
|
+$485K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$420K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$307K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.95M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.06M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.74M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.5M |
| 5 |
Millennium Management
New York
|
-$1.23M |
RCEL Hedge Fund Activity: Q3 2025 in Review
76 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q3 2025, worth a combined $26.3M — down 35% from $40.7M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of RCEL and 16 opened new positions — a net loss of 4 holders — while 35 trimmed existing stakes and 13 added.
The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $522K. The largest seller was BlackRock, cutting an estimated $3.95M.
- 76 institutional investors held Avita Medical (RCEL) as of Q3 2025, down from 80 in Q2 2025.
- Funds reported $26.3M of Avita Medical stock for Q3 2025, down 35% quarter-over-quarter.
- 16 funds opened new Avita Medical positions in Q3 2025 and 20 closed out, a net change of -4 holders.
- The largest Avita Medical buyer in Q3 2025 was Divisadero Street Capital Management, an estimated $522K added.
- The largest Avita Medical seller in Q3 2025 was BlackRock, an estimated $3.95M sold.
Based on aggregated 13F filings for Q3 2025.